Skip to main content
. 2022 Jul;11(7):1130–1139. doi: 10.21037/tp-22-1

Table 2. Neonatal outcome in each group of maternal age.

Outcomes Maternal age (years) Overall P-value P-value for Trend
15–20 21–35 36–55
N 117 6,199 1,382 7,698
Composite outcomea, N (%) 49/117 (41.9) 2,507/6,199 (40.4) 581/1,382 (42.0) 3,137/7,698 (40.8) 0.53 0.35
   Mortality 7/117 (6.0) 297/6,199 (4.8) 67/1,382 (4.8) 371/7,698 (4.8) 0.84 0.90
   NEC ≥ stage II 4/117 (3.4) 282/6,199 (4.5) 61/1,382 (4.4) 347/7,698 (4.5) 0.83 0.99
   Moderate & severe BPD 39/117 (33.3) 1,650/6,183 (26.7) 393/1,378 (28.5) 2,082/7,678 (27.1) 0.12 0.45
   Brain damageb 11/98 (11.2) 561/5,459 (10.3) 121/1,229 (9.8) 693/6,786 (10.2) 0.85 0.59
    Severe IVHb 8/98 (8.2) 350/5,428 (6.4) 84/1,221 (6.9) 442/6,747 (6.6) 0.70 0.77
    cPVLb 4/102 (3.9) 305/5,681 (5.4) 59/1,277 (4.6) 368/7,060 (5.2) 0.47 0.40
   Severe ROPb 5/105 (4.8) 362/5,845 (6.2) 90/1,295 (6.9) 457/7,245 (6.3) 0.67 0.39
   Sepsis 6/117 (5.1) 572/6,199 (9.2) 126/1,382 (9.1) 704/7,698 (9.1) 0.31 0.68

a, composite Outcome included death or at least one of any morbidity including NEC ≥ Stage II, Moderate & Severe BPD, Brain damage, Severe ROP, and sepsis. b, morbidity among newborns who have been screened. NEC, necrotizing enterocolitis; BPD, bronchopulmonary dysplasia; IVH, intraventricular hemorrhage; cPVL, cystic periventricular leukomalacia; ROP, retinopathy of prematurity.